New Products

DALLAS — Kimberly Clark on Wednesday announced the launch of the thin and absorbent Poise Microliners, featuring SAM (Super Absorbent Material).

ENGLEWOOD CLIFFS, N.J. — Klondike, a Unilever brand, has announced Klondike Kandy Bars, which combine the traditional Klondike ice cream with a candy bar shell.

The new bars are offered in three varieties:

PALO ALTO, Calif. and ROCHESTER, Minn. — Better, a consumer health start-up, and Mayo Clinic have launched a new way for people to navigate the healthcare system. 

Through a mobile device, Better provides tailored Mayo Clinic health information to the clinic's nurses, and a Better Personal Health Assistant who helps simplify and manage people's care.

SHELTON, Conn. — BIC, a manufacturer of men’s razors, has developed two new large-pack offerings of the BIC Flex 3 and the BIC Hybrid Advance 3 razors.
 
The BIC Flex 3 large pack includes eight disposable razors that have three flexible blades and a heavy handle for added control.
 

HYDERABAD, India — Dr. Reddy's Labs announced the launch of eszopiclone tablets (C-IV) in 1-mg, 2-mg and 3-mg form. The drug is the generic version of Lunesta (eszopiclone) tablets.

The Lunesta tablets brand and generic combined had sales in the United States of approximately $887 million for the most recent twelve months ending in January 2014, according to IMS Health. Dr. Reddy's eszopiclone tablets 1-mg is available in bottle counts of 30; 2-mg and 3-mg tablets are available in bottle counts of 100.

COLUMBIA, Md. — TheraPearl, a creator of therapy products, announced that its line of hot and cold pearl-filled packs will soon be available in Target stores across the country.

The company's Back Wrap and Sports Pack are already available at Target.com and will make their brick-and-mortar debut in the First Aid section on April 19. While TheraPearl's products have been available in Target Canada since last year, this announcement marks the first appearance of its products in Target's U.S. stores.

PITTSBURGH — Mylan announced that it has launched eszopiclone tablets in 1 mg, 2 mg and 3 mg form. The drug — which is used for the treatment of insomnia — is the generic version of Lunesta from Sunovion Pharmaceuticals.

Mylan received final approval from the Food and Drug Administration for its abbreviated new drug application. Eszopiclone tablets had sales in the U.S. of approximately $851.8 million for the 12 months ending Dec 31, 2013, according to IMS Health.

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday announced that it has approved Tanzeum (albiglutide) subcutaneous injection, which is used to improve glycemic control in adults with Type 2 diabetes.

Type 2 diabetes affects approximately 24 million people and accounts for more than 90% of diabetes cases diagnosed in the United States.